Align Technology, Inc. (NASDAQ: ALGN) is a Healthcare company (Medical - Devices) with a market capitalization of $11.5B. The Maz Rating grades it against the other companies in its sector.
Align Technology, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $163.46, Align Technology, Inc. trades at 23.7x trailing earnings, 2.8x sales and 2.7x book value, with an EV/EBITDA of 14.1. Over the last twelve months it generated about $4.2B of revenue and $486M of net income. It runs a gross margin of 67.6%, an operating margin of 15.0% and a net margin of 11.8%. It shows return on equity of 11.8%, return on invested capital of 10.3% and a free cash flow yield of 5.2%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 1.42. Over the past 52 weeks the share price ranged from $130.23 to $200.44, with a beta of 1.74.
Align Technology, Inc. does not currently pay a dividend.
33 Wall Street analyst ratings cover the stock: 22 Buy, 9 Hold and 2 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.